Published in Vaccine Weekly, March 6th, 2002
Economic development recruiters, lawmakers, politicians and farmers are backing efforts to give more than $3 million in aid to CropTech Corp. if it relocates in North Carolina.
Tobacco is suited well for such bioengineering because it is easily altered at the genetic level and grows quickly, project backers said. CropTech would set up facilities to process the altered tobacco and harvest proteins and other building blocks for new medicines.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.